Glia–immune interactions post-ischemic stroke and potential therapies
Although the primary responsibility of the immune system has for over a century been perceived as the protector of the host against infection in the peripheral organs, we now know the immune system also plays a vital role in recovery pathways associated with central nervous system (CNS) injury. Ther...
Gespeichert in:
Veröffentlicht in: | Experimental biology and medicine (Maywood, N.J.) N.J.), 2018-12, Vol.243 (17-18), p.1302-1312 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Although the primary responsibility of the immune system has for over a century been
perceived as the protector of the host against infection in the peripheral organs, we now
know the immune system also plays a vital role in recovery pathways associated with
central nervous system (CNS) injury. There is mounting evidence that the blood–brain
barrier does not preclude the CNS from immune surveillance. Of particular interest for
this review is how microglia and astrocytes interact with the cells of the immune system
to modulate repair and recovery mechanisms in ischemic stroke. Our review argues that by
deepening our understanding of neuroimmunity, specifically the bidirectional glial–immune
cell communications, a plethora of new therapeutic targets and mechanisms may be revealed.
Consequently, this review instigates novel experimental approaches to neuroimmunology and
fosters a more rapid discovery process for the treatment of stroke.
Impact statement
This article reviews glial cell interactions with the immune system post-ischemic
stroke. Research has shown that glial cells in the brain play a role in altering
phenotypes of other glial cells and have downstream immune cell targets ultimately
regulating a neuroinflammatory response. These interactions may play a deleterious as
well as beneficial role in stroke recovery. Furthermore, they may provide a novel way to
approach potential therapies, since current stroke drug therapy is limited to only one
Food and Drug Administration-approved drug complicated by a narrow therapeutic window.
Until this point, most research has emphasized neuroimmune interactions, but little
focus has been on bidirectional communication of glial–immune interactions in the
ischemic brain. By expanding our understanding of these interactions through a
compilation of glial cell effects, we may be able to pinpoint major modulating factors
in brain homeostasis to maintain or discover ways to suppress irreversible ischemic
damage and improve brain repair. |
---|---|
ISSN: | 1535-3702 1535-3699 |
DOI: | 10.1177/1535370218818172 |